# A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss

> **NCT06761703** · — · COMPLETED · sponsor: **Amgen** · enrollment: 200 (actual)

## Conditions studied

- Obesity

## Interventions

- **DEVICE:** TAP® Micro Select Device (Touch Activated Phlebotomy)

## Key facts

- **NCT ID:** NCT06761703
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-14
- **Primary completion:** 2025-01-06
- **Final completion:** 2025-01-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06761703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06761703, "A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06761703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*